title: [Combination therapy for rheumatoid arthritis].
abstract: What can be expected from combination therapy? What is the goal of combination therapy? What criteria allow drug selection? Is combination therapy regularly used for controlling rheumatoid arthritis? What combination therapies have been assessed with clinical trials? What is the contribution of prolonged combination therapy? Conclusion
authors: Service de Rhumatologie, Hôpital de Hautepierre, CHU, 67098 Strasbourg Cedex, France. jean.sibilia@wanadoo.fr
authors: Jean
authors: J
authors: Sibilia
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D008727:Methotrexate / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D000069285:Infliximab; D008727:Methotrexate